Cite
HARVARD Citation
Span, P. et al. (n.d.). Improved metastasis‐free survival in nonadjuvantly treated postmenopausal breast cancer patients with chemokine receptor 5 del32 frameshift mutations. International journal of cancer. 136 (1), pp. 91-97. [Online].